ozempic vs semaglutide compound Drugmakers battle pharmacies over compounded and Zepbound : Shots The Risks of Compounded Semaglutide

(Mounjaro, Zepbound) and rival Novo Nordisk A/S (Ozempic, Wegovy) have become a veritable gold mine, one projected to reach $100 billion within the next seven years

The first 4-6 weeks involve adaptation with mostly water weight and glycogen changes

This is both good news (no withdrawal concerns) and a reflection of the modest magnitude of effects compared to prescription therapies

Supplements that activate GLP-1

Effects of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon on various vital organs and tissues

Yet subcutaneous injections of recombinant GLP-1 were a disappointment in patients, falling short of prior results with intravenous GLP-1